Skip to main content

Table 2 Demographic and clinical characteristics of the Parkinson’s disease patient groups n = 96

From: Caregiver burden is increased in Parkinson’s disease with mild cognitive impairment (PD-MCI)

Patient groups

PD-N

(n = 51)

PD-MCI (n = 30)

PDD

(n = 15)

Analysis

Significant post-hoc differences (N-K or T2)

Age

68.23 ± 7.60

69.5 ± 6.86

72.73 ± 4.85

F2,93 = 2.39, p = .09

 

Female: Male

16/35

9/21

3/12

X 2 = .74, p = .69

 

Education (yrs)

13.14 ± 3.03

12.56 ± 1.99

12.26 ± 2.49

F2,93 = .82, p = .44

 

GDS

1.45 ± 2.88

0.73 ± 1.79

2.13 ± 3.14

F2,93 = 1.29, p = .28

 

H&Y

2.10 ± 0.52

2.30 ± 0.75

2.33 ± 0.59

F2, 90 = 1.48, p = .23

 

NPI

3.14 ± 5.21

4.37 ± 4.62

8.13 ± 9.26

F2, 89 = 4.83, p < .05

PD-N v PDD, p < .05

ADL-IS

.51 ± 0.51

.78 ± 0.47

2.04 ± 0.54

F2,91 = 55.35, p < .0001

PD-N v PDD, p < .001

PD-MCI v PDD, p < .001

Disease Duration (yrs)

7.54 ± 4.00

9.10 ± 4.44

11.63 ± 6.92

F2, 93 = 4.59, p < .05

 

UPDRS-III

25.64 ± 10.80

29.2 ± 13.07

34.83 ± 10.42

F2,92 = 3.84, p < .05

PD-N v PDD, p < .05

  1. Values reported as mean ± standard deviation: GDS-Geriatric Depression Scale; H&Y- Hoehn & Yahr; NPI - Neuropsychiatric Inventory; ADL-IS Activities of Daily Living - International Scale (max = 4.0); UPDRS-III Unified Parkinson’s Disease Rating Scale Part III